Jennifer B. Green - Publications

A Validated, Modifiable Proteomic Score from the EXSCEL Trial Predicts Cardiovascular Events in Diabetes.

Journal: JCI insight

Published: July 02, 2026

Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: June 05, 2026

Sexual Dimorphism and Age Effects in CKD and Type 2 Diabetes in the CONFIDENCE Trial.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: March 27, 2026

Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.

Journal: Diabetes, obesity & metabolism

Published: February 23, 2026

CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum.

Journal: Cardiovascular diabetology

Published: January 26, 2026

Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone.

Journal: Journal of the American Society of Nephrology : JASN

Published: January 14, 2026

Selective Internal Radiation Therapy (SIRT) for Hepatocellular Carcinoma: Real-World Experience from a Tertiary Care Centre.

Journal: Journal of clinical medicine

Published: December 30, 2025

From global guidelines for cardio-kidney-metabolic diseases management to national implementation: perspectives from the guideline workshop taskforce.

Journal: Cardiovascular diabetology

Published: December 03, 2025

Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both: Post Hoc Analyses of CONFIDENCE Trial.

Journal: Journal of the American Society of Nephrology : JASN

Published: September 26, 2025

Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of the CONFIDENCE Randomized Trial.

Journal: Journal of the American College of Cardiology

Published: September 17, 2025

Fat, muscle, and anti-obesity medications in cardiovascular disease prevention.

Journal: European heart journal

Published: September 16, 2025

Overcoming Barriers to Developing and Implementing Novel Therapies for Hypertension.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: August 28, 2025